Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SUPERIO BIO AS
AS
Active
Org 935412242
Gaustadalléen 21, 0349
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
— employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
SUPERIO BIO AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
NOK thousands
Item
2025
Revenue
372
Staff expenses
−85
EBITDA
−23
Depreciation & amort.
−5
EBIT
−28
Net financials
−0
Profit before tax
−28
Tax
−0
Net profit
−28
Balance sheet
NOK thousands
Item
2025
Total assets
472
Equity
2
Long-term debt
0
Short-term debt
470
Total debt
470
Financial ratios
5-year trend
EBITDA margin
-6.1%
This company
15.8%
Market median
-139% vs market
2025
2025
Equity ratio
0.4%
This company
38.2%
Market median
-99% vs market
2025
2025
Return on equity
-1417.5%
This company
18.4%
Market median
-7804% vs market
2025
2025
Net profit margin
-7.5%
This company
8.1%
Market median
-193% vs market
2025
2025
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
2025
2025
Debt / equity
237.80×
This company
0.62×
Market median
-38255% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-04-09 – 2025-12-31
View
PDF
More on SUPERIO BIO AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
